Rathinaraj et al. obtained herceptin (anti-HER-2/neu monoclonal antibody) immobilized on 29 nm Au NPs improving the interaction of this drug with the suitable receptors on the surface of the breast cancer cells (SK-BR3) [44]. Here, ERBB2 is linked to breast carcinoma.